Andere talen Bristol-Myers Squibb Company

Aandelen

BMY

US1101221083

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 06-02-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
61,99 ^USD	+4,15%		+12,61%	+14,92%

06/02	BRISTOL-MYERS SQUIBB COMPANY : Morgan Stanley handhaaft het verkoopadvies	ZM
06/02	BRISTOL-MYERS SQUIBB COMPANY : Een koopadvies van Leerink Partners	ZM

Andere talen

05/02	Aktien New York Schluss: Schwach - Jobdaten, KI und Krypto verunsichern
05/02	Sector Update: Health Care Stocks Softer Late Afternoon
05/02	Bayer says its experimental blood thinner cuts risk of stroke recurrence by 26%
05/02	Sector Update: Health Care Stocks Softer Thursday Afternoon
05/02	From jitters on Wall Street: skepticism grows around AI
05/02	De la nervosité à Wall Street : le scepticisme grandit autour de l'IA
05/02	Aktien New York: Deutliche Verluste - Alphabet mit enormen KI-Ausgaben
05/02	Bristol Myers forecasts upbeat 2026, expects Eliquis price cut to pay off
05/02	Sector Update: Health Care Stocks Lean Lower Premarket Thursday
05/02	Sector Update: Health Care
05/02	Bristol-Myers Squibb expects 2026 adjusted EPS $6.05 to $6.35 vs IBES estimate $6.02
05/02	Tech Set to Drag Wall Street Down Again After Alphabet and Qualcomm
05/02	Bristol-Myers Squibb Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
05/02	Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off
05/02	La tech devrait encore plomber Wall Street après Alphabet et Qualcomm
05/02	Aktien New York Ausblick: Für Dow sind 50.000 Punkte weiterhin zu hohe Hürde
05/02	Bristol-Myers Q4 Non-GAAP Earnings Fall, Revenue Rises; 2026 Guidance Set -- Shares Up Pre-Bell
05/02	Earnings Flash (BMY) Bristol-Myers Squibb Posts Q4 Revenue $12.50B, vs. FactSet Est of $12.28B
05/02	Earnings Flash (BMY) Bristol-Myers Squibb Posts Q4 Adjusted EPS $1.26, vs. FactSet Est of $1.23
05/02	Bristol Myers Squibb : Myers dépasse de peu les attentes de BPA trimestriel
05/02	Bristol Myers Squibb 4Q Revenue Ticks Up on Immuno-Oncology Growth
05/02	Bristol Myers: Q4 Earnings Snapshot
05/02	Bristol Myers Squibb : Q4 2025 Results Presentation
05/02	Bristol Myers Squibb : Q4 2025 Results Presentation (with Appendix)
05/02	Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen Bristol-Myers Squibb Company

Aandelen

BMY

US1101221083

Farmaceutische producten

Andere talen

Filters